About this trial
The decision to perform a surgical intervention or not after recovery from repeated uncomplicated episodes of acute diverticulitis remains controversial and the literature shows different conflicting approaches based on low-quality evidence.The goal of this trial is to achieve a better understanding of the impact of surgery on bowel function and QoL in patients with recurrent uncomplicated sigmoid diverticulitis in order to develop treatment guidelines.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients with recurrent uncomplicated diverticulitis and surgical indication for sigmoid resection
Patients with recurrent uncomplicated diverticulitis and non-surgical indication for conservative management
Confirmation of at least one episode of acute uncomplicated diverticulitis in computed tomography
Disqualifiers
Patients aged under 18.
Patients unable to understand an informed consent.
Patients with chronic pain disorder.
Patients with sigmoid fistulas
Trial population
Patients with recurrent episodes of diverticulitis with indication of further treatment.The physician decides which therapy (conservative or surgical) will be carried out.
Trial design
Cohort
Prospective
Treatments tested in this trial
elective sigmoidectomy
Procedure/Surgeryelective sigmoidectomy
Treatment groups
Trial outcomes
Primary outcomes
Change in grade of fecal incontinence incontinence score
Fecal incontinence measured by total "Vaizey-Wexner incontinence score" ranging from 0 to 24; lower values represent better outcome
Change in grade of constipation
Constipation measured by total "Cleveland constipation score" ranging from 0 to 30; lower values represent better outcome
Secondary outcomes
Change in gastrointestinal quality of Life: gastrointestinal quality of life score" (GIQLI score)
Gastrointestinal quality of life measured by total "gastrointestinal quality of life score" (GIQLI score) ranging from 0-144; higher values represent better outcome
Change in erectile function
Erectile function measured by total "international index of erectile function" (IIEF-5-score) ranging from 5 to 25; higher values represent better outcome
Sponsors and contacts
Click on the lead sponsor to view all of their trials.